The diverse functionality of mTOR provides a very attractive drug target where dysfunctional mTOR signalling can lead to diseases such as cancer, type II diabetes, obesity, aging and neurodegenerative conditions [12]. Here, MTOR is linked to obesity due to melanocortin 4 receptor deficiency.